Nascobal: profile and news

Nastech Blows It Mar 2, 2006
...program completely?". Nastech has one product on the market, Nascobal, a nasal gel for vitamin B12 deficiencies. Its osteoporosis ... - Smartmoney.com

Questcor Announces the Addition of George Stuart as Chief ... Sep 28, 2005
...the US: HP Acthar(R) Gel (repository corticotropin injection), an injectable drug that is commonly used for certain neurological conditions; Nascobal(R), the ... - Business Wire (press release),

Questcor Announces Financial Results for Second Quarter 2005 Aug 11, 2005
Increased net product sales of HP Acthar(R) Gel, offset in part by lower Nascobal(R) net product sales, contributed to higher net product sales and total ... - PharmaLive.com (press release),

Nastech Announces Second Quarter 2005 Financial Results Aug 1, 2005
Also, the company received and recognized a $2.0 million milestone in the first quarter of 2005 from the FDA approval of Nascobal(R) spray. ... - PharmaLive.com (press release)

Questcor Appoints Gregg Lapointe to Its Board of Directors Jul 6, 2005
...the US: HP Acthar(R) Gel (repository corticotropin injection), an injectable drug that is commonly used for certain neurological conditions; Nascobal(R), the ... - Business Wire (press release) <**results**>

Questcor to Webcast Annual Meeting Presentation May 31, 2005
...the US: HP Acthar(R) Gel (repository corticotropin injection), an injectable drug that is commonly used for certain neurological conditions; Nascobal(R), the ... - PharmaLive.com (press release),

Vitamin B12 Taken Nasally Can Help Patients Starve off Anemia ... Apr 4, 2005
Nascobal®, a prescription nasal vitamin B12 supplement, can make maintenance easier. ... Most people using Nascobal experience no side effects. ... - Khalsa News Network

Questcor Pharmaceuticals Announces New Business Strategy; Company ... Apr 13, 2005
...the US: HP Acthar(R) Gel (repository corticotropin injection), an injectable drug that is commonly used for certain neurological conditions; Nascobal(R), the ... - Business Wire,

Product investments add to Nastech's losses Mar 2, 2005
In 2003, Nastech sold Nascobal, a treatment for Vitamin B12 deficiency, to a California company that has a sales and marketing force. ... - Seattle Post Intelligencer

Questcor Updates Revenue Guidance for 2004 and Reports on Progress ... Feb 18, 2005
...following the recent FDA approval of the Nascobal (Cyanocobalamin, USP) spray for intranasal administration. Under the terms of ... - Business Wire (press release),

Nastech Announces 2004 Financial Results Mar 2, 2005
...in 2004, non-recurring prior year revenue from the apomorphine program with Pharmacia, and a prior year gain on the asset sale of Nascobal(R). Research and ... - PR Newswire (press release)

Questcor Announces Year End Earnings Call Mar 7, 2005
...the US: HP Acthar(R) Gel (repository corticotropin injection), an injectable drug that is commonly used for certain neurological conditions; Nascobal(R), the ... - Business Wire (press release),